INMB
INmune Bio Inc
NASDAQ: INMB · HEALTHCARE · BIOTECHNOLOGY
$1.33
-5.00% today
Updated 2026-04-29
Market cap
$39.08M
P/E ratio
—
P/S ratio
781.61x
EPS (TTM)
$-1.86
Dividend yield
—
52W range
$1 – $8
Volume
0.4M
INmune Bio Inc (INMB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+26.5%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+54.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+7.9%
2026-03-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.20 | — | $1.14 | $1.23 | +7.9% |
| 2025-12-31 | $-0.18 | +33.3% | $1.60 | $1.54 | -3.8% |
| 2025-10-29 | $-0.24 | +26.2% | $1.82 | $1.73 | -4.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | — | $-0.20 | — | — | — |
| 2025-12-31 | $-0.27 | $-0.18 | +33.3% | — | — |
| 2025-09-30 | $-0.33 | $-0.24 | +26.2% | — | — |
| 2025-06-30 | $-0.43 | $-0.34 | +20.1% | — | — |
| 2025-03-31 | $-0.49 | $-0.43 | +12.2% | $50000.00 | +257.1% |
| 2024-12-31 | $-0.54 | $-0.40 | +25.9% | — | — |
| 2024-09-30 | $-0.50 | $-0.60 | -20.0% | — | — |
| 2024-06-30 | $-0.63 | $-0.50 | +20.6% | — | — |
| 2024-03-31 | $-0.53 | $-0.61 | -15.1% | $14000.00 | — |
| 2023-12-31 | $-0.44 | $-0.47 | -6.8% | $28000.00 | — |
| 2023-09-30 | $-0.39 | $-0.48 | -23.1% | $43000.00 | — |
Frequently asked questions
Has INmune Bio Inc beaten earnings estimates?
INmune Bio Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +26.5% over the last 3 quarters.
How does INMB stock react to earnings?
INMB stock has moved an average of -0.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.